{ }
001122334455554433221100
001122334455554433221100

FDA approves POLARx Cryoablation System for treating paroxysmal atrial fibrillation

The FDA has approved the POLARx Cryoablation System for treating paroxysmal atrial fibrillation. Meanwhile, Amneal Pharmaceuticals filed a New Drug Application for PEMRYDI RTU, aimed at non-squamous non-small cell lung cancer and malignant pleural mesothelioma. The global pleural diseases market is projected to grow, with thoracentesis expected to dominate treatment options, particularly in North America, driven by increasing healthcare investments and a rising geriatric population.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Machinary - Dashboard

Client connection lost

Please check your connection. We try to reconnect...

Server connection lost

If our server is updating to a new version, please wait a moment before the service is available again.

Connection refused

All connection attempts have been rejected. This is most likely due to network problems or server problems.